JP Morgan Chase’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-85,000
Closed -$893K 7229
2025
Q1
$893K Buy
+85,000
New +$962K ﹤0.01% 4430
2022
Q4
Sell
-150,000
Closed -$1.86M 6648
2022
Q3
$1.86M Buy
+150,000
New +$2.62M ﹤0.01% 3534

Other funds holding ELAN

JP Morgan Chase's ELAN Position: Q2 2026 in Review

JP Morgan Chase reduced its Elanco Animal Health (ELAN) stake by 1.6% in Q2 2026, selling an estimated $740K and leaving 1,922,899 shares worth $48.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

JP Morgan Chase first reported a position in ELAN in Q3 2018 and has held it in 32 quarters since. The position peaked at $218M in Q2 2019. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • JP Morgan Chase held 1,922,899 shares of Elanco Animal Health worth $48.1M as of Q2 2026.
  • JP Morgan Chase sold 31,989 Elanco Animal Health shares in Q2 2026, an estimated $740K.
  • Elanco Animal Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1508 holding.
  • JP Morgan Chase first reported a position in Elanco Animal Health in Q3 2018 and has held it in 32 quarters since.
  • JP Morgan Chase's Elanco Animal Health position peaked at $218M in Q2 2019.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.